14 results on '"Zhang, Xueli"'
Search Results
2. Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis.
- Author
-
Fan, Chuanwen, Fang, Chao, Wang, Wei, Lv, Zhaoying, Zhang, Xueli, Long, Feiwu, Jiang, Zongze, Li, Yuan, Zhang, Hong, Zhou, Zong‐Guang, Wang, Cun, and Sun, Xiao‐Feng
- Subjects
PROTEIN deficiency ,COLORECTAL cancer ,GENE regulatory networks ,METASTASIS ,GENE expression - Abstract
Background: While previous studies have indicated variability in distant metastatic potential among different mismatch repair (MMR) states in colorectal cancer (CRC), their findings remain inconclusive, especially considering potential differences across various ethnic backgrounds. Furthermore, the gene regulatory networks and the underlying mechanisms responsible for these variances in metastatic potential across MMR states have yet to be elucidated. Methods: We collected 2058 consecutive primary CRC samples from the South West of China and assessed the expression of MMR proteins (MLH1, MSH2, MSH6, and PMS2) using immunohistochemistry. To explore the inconsistencies between different MMR statuses and recurrence, we performed a meta‐analysis. To delve deeper, we employed Weighted Gene Co‐expression Network Analysis (WGCNA), ClueGo, and iRegulon, pinpointing gene expression networks and key regulatory molecules linked to metastasis and recurrence in CRC. Lastly, both univariate and multivariate Cox regression analyses were applied to determine the impact of core regulatory molecules on metastasis. Results: Of the samples, 8.2% displayed deficient MMR (dMMR), with losses of MLH1 and PSM2 observed in 40.8% and 63.9%, respectively. A unique 24.3% isolated loss of PMS2 without concurrent metastasis was identified, a result that diverges from established literature. Additionally, our meta‐analysis further solidifies the reduced recurrence likelihood in dMMR CRC samples compared to proficient MMR (pMMR). Two gene expression networks tied to distant metastasis and recurrence were identified, with a majority of metastasis‐related genes located on chromosomes 8 and 18. An IRF1 positive feedback loop was discerned in the metastasis‐related network, and IRF1 was identified as a predictive marker for both recurrence‐free and distant metastasis‐free survival across multiple datasets. Conclusion: Geographical and ethnic factors might influence peculiarities in MMR protein loss. Our findings also highlight new gene expression networks and crucial regulatory molecules in CRC metastasis, enhancing our comprehension of the mechanisms driving distant metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Whole‐transcriptome defines novel glucose metabolic subtypes in colorectal cancer.
- Author
-
Li, Shaohua, Fang, Wei, Zheng, Jianfeng, Peng, Zhiqiang, Yu, Biyue, Chen, Chunhui, Zhang, Yuting, Jiang, Wenli, Yuan, Shuhui, Zhang, Lingqiang, and Zhang, Xueli
- Subjects
SECRETED frizzled-related proteins ,COLORECTAL cancer ,GLUCOSE ,NONNEGATIVE matrices ,MATRIX decomposition - Abstract
Colorectal cancer (CRC) is the most prevalent malignancy of the digestive system. Glucose metabolism plays a crucial role in CRC development. However, the heterogeneity of glucose metabolic patterns in CRC is not well characterized. Here, we classified CRC into specific glucose metabolic subtypes and identified the key regulators. 2228 carbohydrate metabolism‐related genes were screened out from the GeneCards database, 202 of them were identified as prognosis genes in the TCGA database. Based on the expression patterns of the 202 genes, three metabolic subtypes were obtained by the non‐negative matrix factorization clustering method. The C1 subtype had the worst survival outcome and was characterized with higher immune cell infiltration and more activation in extracellular matrix pathways than the other two subtypes. The C2 subtype was the most prevalent in CRC and was characterized by low immune cell infiltration. The C3 subtype had the smallest number of individuals and had a better prognosis, with higher levels of NRF2 and TP53 pathway expression. Secreted frizzled‐related protein 2 (SFRP2) and thrombospondin‐2 (THBS2) were confirmed as biomarkers for the C1 subtype. Their expression levels were elevated in high glucose condition, while their knockdown inhibited migration and invasion of HCT 116 cells. The analysis of therapeutic potential found that the C1 subtype was more sensitive to immune and PI3K‐Akt pathway inhibitors than the other subtypes. To sum up, this study revealed a novel glucose‐related CRC subtype, characterized by SFRP2 and THBS2, with poor prognosis but possible therapeutic benefits from immune and targeted therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. CBD2: A functional biomarker database for colorectal cancer.
- Author
-
Zhang, Xueli, Li, Min, Ye, Siting, Shen, Ke, Yuan, Haining, Bakhtyar, Shoaib, Peng, Qiliang, Liu, Yongsheng, Wang, Yingying, Li, Manshi, Zhang, Chi, Wang, Yixin, Bai, Xiaohe, Liu, Shunming, Zhao, Ke, Shen, Bairong, Repsilber, Dirk, Hu, Guang, Zhang, Hong, and Sun, Xiao‐Feng
- Subjects
- *
COLORECTAL cancer , *DATABASES , *TUMOR markers , *GENE ontology , *BIOMARKERS , *INDIVIDUALIZED medicine - Abstract
The rapidly evolving landscape of biomarkers for colorectal cancer (CRC) necessitates an integrative, updated repository. In response, we constructed the Colorectal Cancer Biomarker Database (CBD), which collected and displayed the curated biomedicine information for 870 CRC biomarkers in the previous study. Building on CBD, we have now developed CBD2, which includes information on 1569 newly reported biomarkers derived from different biological sources (DNA, RNA, protein, and others) and clinical applications (diagnosis, treatment, and prognosis). CBD2 also incorporates information on nonbiomarkers that have been identified as unsuitable for use as biomarkers in CRC. A key new feature of CBD2 is its network analysis function, by which users can investigate the visible and topological network between biomarkers and identify their relevant pathways. CBD2 also allows users to query a series of chemicals, drug combinations, or multiple targets, to enable multidrug, multitarget, multipathway analyses, toward facilitating the design of polypharmacological treatments for CRC. CBD2 is freely available at http://www.eyeseeworld.com/cbd. Highlights: CBD2 integrates biomarkers derived from diverse biological sources and clinical applications, employing a standardized approach for annotation and classification.CBD2 facilitates precision medicine in colorectal cancer by providing abundant data, including drug–target information and visualized network analysis functions.With its user‐friendly interface, CBD2 aids in the identification and development of biomarkers for colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer.
- Author
-
Xu, Chunjie, Gu, Lei, Hu, Lipeng, Jiang, Chunhui, Li, Qing, Sun, Longci, Zhou, Hong, Liu, Ye, Xue, Hanbing, Li, Jun, Zhang, Zhigang, Zhang, Xueli, and Xu, Qing
- Subjects
MICROBIAL ecology ,COLORECTAL cancer ,ARACHIDONIC acid ,ESSENTIAL fatty acids ,UNSATURATED fatty acids ,INTESTINES - Abstract
Colonocyte metabolism shapes the microbiome. Metabolites are the main mediators of information exchange between intestine and microbial communities. Arachidonic acid (AA) is an essential polyunsaturated fatty acid and its role in colorectal cancer (CRC) remains unexplored. In this study, we show that AA feeding promotes tumor growth in AOM/DSS and intestinal specific Apc
−/− mice via modulating the intestinal microecology of increased gram-negative bacteria. Delta-5 desaturase (FADS1), a rate-limiting enzyme, is upregulated in CRC and effectively mediates AA synthesis. Functionally, FADS1 regulates CRC tumor growth via high AA microenvironment-induced enriched gram-negative microbes. Elimination of gram-negative microbe abolishes FADS1 effect. Mechanistically, gram-negative microbes activate TLR4/MYD88 pathway in CRC cells that contributes FADS1-AA axis to metabolize to prostaglandin E2 (PGE2). Cumulatively, we report a potential cancer-promoting mechanism of FADS1-AA axis in CRC that converts raising synthesized AA to PGE2 via modulating the intestinal microecology of gram-negative. The role of arachidonic acid (AA) in colorectal cancer (CRC) is unclear. Here they show that FADS1-AA axis modulates the intestinal microecology by enriching gram-negative bacteria in CRC and that the altered microecology accelerates the conversion of AA to PGE2, promoting CRC tumorigenesis. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
6. Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS/BACH1 axis.
- Author
-
Chen, Tianwei, Zhang, Xilin, Ding, Xufen, Feng, Jing, Zhang, Xueli, Xie, Dong, and Wang, Xiang
- Abstract
There is no targeted therapy for KRAS proto‐oncogene, GTPase (KRAS)‐mutant metastatic colorectal cancer (mCRC) because the underlying mechanism remains obscure. Based on bioinformatic analysis, this study aims to elucidate a potential gene target for which an approved drug is available, and to reveal the function as well as the underlying mechanism of the candidate gene. Here, we identified that ryanodine receptor 2 (RyR2) expression was upregulated in KRAS‐mutant mCRC, and that this promoted cancer cell metastasis. S107, an approved drug to inhibit calcium release from RyR2 in the clinic, inhibited cancer cell metastasis both in vitro and in vivo. High expression of RyR2 predicts poor survival in our patient cohort. CRC patients with serosa invasion and vascular tumor thrombus are characterized by high RyR2 expression. Analysis of expression profiles upon RyR2 knockdown and inhibition, revealed a set of metastasis‐related molecules, and identified BTB domain and CNC homolog 1 (BACH1) as the main transcription factor regulated by RyR2. RyR2 regulates cellular reactive oxygen species (ROS) levels, which activates nuclear factor erythroid 2‐related factor 2 (Nrf2; also known as NFE2L2) and HMOX1 expression, and thus BACH1 accumulation. Collectively, this study provides evidence that the RyR2/ROS/BACH1 axis may be a potential intervention target for CRC metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis
- Author
-
Zhang, Xueli, Wu, Liang, Sheng, Youhua, Zhou, Wenhua, Huang, Zhongming, Qu, Jun, Gao, Ganglong, Cai, Duan, and Zhang, Ming
- Published
- 2012
- Full Text
- View/download PDF
8. CircASXL1 knockdown represses the progression of colorectal cancer by downregulating GRIK3 expression by sponging miR-1205.
- Author
-
Fang, Guojiu, Wu, Yibin, and Zhang, Xueli
- Subjects
COLORECTAL cancer ,CANCER invasiveness ,CIRCULAR RNA ,POLYMERASE chain reaction ,CELL migration - Abstract
Background: Colorectal cancer (CRC) is a common aggressive tumor that poses a heavy burden to human health. An increasing number of studies have reported that circular RNA (circRNA) is involved in the progression of CRC. In this study, the special profiles of circASXL1 (circ_0001136) in CRC progression were revealed. Methods: The expression of circASXL1, microRNA-1205 (miR-1205), and glutamate ionotropic receptor kainate type subunit 3 (GRIK3) mRNA was detected by quantitative real-time polymerase chain reaction (qRT-PCR). The protein expression was determined by Western blot or immunohistochemistry. Cell colony-forming ability was investigated by colony formation assay. Cell cycle and apoptosis were demonstrated using cell-cycle and cell-apoptosis analysis assays, respectively. Cell migration and invasion were detected by wound-healing and transwell migration and invasion assays, respectively. The binding sites between miR-1205 and circASXL1 or GRIK3 were predicted by circBank or miRDB online database, and identified by dual-luciferase reporter assay. The impact of circASXL1 on tumor formation in vivo was investigated by in vivo tumor formation assay. Results: CircASXL1 and GRIK3 expression were apparently upregulated, and miR-1205 expression was downregulated in CRC tissues and cells relative to control groups. CircASXL1 knockdown inhibited cell colony-forming ability, migration and invasion, whereas induced cell arrest at G0/G1 phase and cell apoptosis in CRC cells; however, these effects were attenuated by miR-1205 inhibitor. Additionally, circASXL1 acted as a sponge for miR-1205, and miR-1205 was associated with GRIK3. Furthermore, circASXL1 silencing hindered tumor formation by upregulating miR-1205 and downregulating GRIK3 expression. Conclusion: CircASXL1 acted an oncogenic role in CRC malignant progression via inducing GRIK3 through sponging miR-1205. Our findings provide a theoretical basis for studying circASXL1-directed therapy for CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β‐catenin signaling.
- Author
-
Li, Liang, Duan, Qiuhui, Zeng, Zhiyang, Zhao, Jindong, Lu, Jiawei, Sun, Jialiang, Zhang, Jiqin, Siwko, Stefan, Wong, Jiemin, Shi, Tieliu, Zhang, Xueli, Liu, Mingyao, Chen, Jinlian, and Li, Dali
- Subjects
INTESTINAL tumors ,WNT signal transduction ,PROTEIN stability ,NEOPLASTIC cell transformation ,COLON cancer ,STEM cells - Abstract
Intestinal tumors mainly originate from transformed crypt stem cells supported by Wnt signaling, which functions through downstream critical factors enriched in the intestinal stem/progenitor compartment. Here, we show Uhrf2 is predominantly expressed in intestinal crypts and adenomas in mice and is transcriptionally regulated by Wnt signaling. Upregulated UHRF2 correlates with poor prognosis in colorectal cancer patients. Although loss of Uhrf2 did not affect intestinal homeostasis and regeneration, tumor initiation and progression were inhibited, leading to a markedly prolonged life span in Uhrf2 null mice on an ApcMin background. Uhrf2 deficiency also strongly reduced primary tumor organoid formation suggesting impairment of tumor stem cells. Moreover, ablation of Uhrf2 suppressed tumor cell proliferation through downregulation of the Wnt/β‐catenin pathway. Mechanistically, Uhrf2 directly interacts with and sumoylates Tcf4, a critical intranuclear effector of the Wnt pathway. Uhrf2 mediated SUMOylation stabilized Tcf4 and further sustained hyperactive Wnt signaling. Together, we demonstrate that Wnt‐induced Uhrf2 expression promotes tumorigenesis through modulation of the stability of Tcf4 for maintaining oncogenic Wnt/β‐catenin signaling. This is a new reciprocal feedforward regulation between Uhrf2 and Wnt signaling in tumor initiation and progression. What's new? UHRF2 has been shown to be enriched in intestinal stem cells and upregulated in colorectal cancer. However, the role of UHRF2 in intestinal homeostasis and tumorigenesis has not been explored in vivo. This study shows that Uhrf2 is expressed in mouse intestinal crypts and adenomas and is transcriptionally regulated by Wnt signaling. Uhrf2 further maintains oncogenic Wnt/β−catenin signaling through modulation of Tcf4 protein stability to enhance the stemness and tumorigenicity of intestinal progenitors. The findings reveal reciprocal feedforward regulation between Uhrf2 and Wnt signaling in tumor initiation and progression, and highlight Uhrf2 as a potential therapeutic target in colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. CRC-EBD: Epigenetic Biomarker Database for Colorectal Cancer.
- Author
-
Liu, Xingyun, Zhang, Xueli, Chen, Jing, Ye, Benchen, Ren, Shumin, Lin, Yuxin, Sun, Xiao-Feng, Zhang, Hong, and Shen, Bairong
- Subjects
COLORECTAL cancer ,BIOMARKERS ,EPIGENOMICS ,EPIGENETICS ,CIRCULATING tumor DNA ,DATABASES - Published
- 2020
- Full Text
- View/download PDF
11. STAT3 repressed USP7 expression is crucial for colon cancer development
- Author
-
Shan Yuanzhou, Yang Zhi, Zhang Xueli, Yao Kai, Li Xianwei, Huo ShouJun, Liu Haijun, and Xu Yume
- Subjects
STAT3 Transcription Factor ,Colorectal cancer ,Biophysics ,Down-Regulation ,Histone Deacetylase 1 ,Biology ,Transfection ,Biochemistry ,Metastasis ,STAT3 ,Ubiquitin-Specific Peptidase 7 ,Structural Biology ,Cell Line, Tumor ,Genetics ,medicine ,Humans ,RNA, Messenger ,RNA, Neoplasm ,Promoter Regions, Genetic ,Molecular Biology ,P53 ,Binding Sites ,Interleukin-6 ,Protein Stability ,HEK 293 cells ,Cell Biology ,medicine.disease ,HCT116 Cells ,HDAC1 ,Colon cancer ,HEK293 Cells ,Cell culture ,Colonic Neoplasms ,Cancer research ,biology.protein ,USP7 ,Signal transduction ,Tumor Suppressor Protein p53 ,Ubiquitin Thiolesterase ,Metabolic Networks and Pathways ,Signal Transduction - Abstract
Interleukin-6 (IL-6) induced STAT3 activation is viewed as crucial for multiple tumor growth and metastasis, including colon cancer. However, the molecular mechanisms remain largely unexplored. Here, we show that expression of ubiquitin-specific protease 7 (USP7), a deubiquitylating enzyme, is decreased in STAT3-positive tumors. IL-6 administration or transfection of a constitutively activated STAT3 in SW480 cells also repressed USP mRNA expression. Using luciferase reporter and ChIP assay, we found that STAT3 bound to the promoter region of USP7 and inhibited its activity through recruiting HDAC1. As a result of the decline of USP7 expression, endogenous P53 protein level was decreased. Thus, our results suggest a previously unknown STAT3-USP7-P53 molecular network controlling colon cancer development.Structured summary of protein interactions:STAT3 physically interacts with HDAC1 by anti bait coimmunoprecipitation (View interaction)
- Published
- 2012
12. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
- Author
-
Zhang, Long, Li, Liang, Gao, Ganglong, Wei, Gaigai, Zheng, Yansen, Wang, Chunmei, Gao, Na, Zhao, Yongliang, Deng, Jiong, Chen, Huaqing, Sun, Jialiang, Li, Dali, Zhang, Xueli, and Liu, Mingyao
- Abstract
The clearance of oxidative stress compounds is critical for the protection of the organism from malignancy, but how this key physiological process is regulated is not fully understood. Here, we found that the expression of GPRC5A, a well-characterized tumor suppressor in lung cancer, was elevated in colorectal cancer tissues in patients. In both cancer cell lines and a colitis-associated cancer model in mice, we found that GPRC5A deficiency reduced cell proliferation and increased cell apoptosis as well as inhibited tumorigenesis in vivo. Through RNA-Seq transcriptome analysis, we identified oxidative stress associated pathways were dysregulated. Moreover, in GPRC5A deficient cells and mouse tissues, the oxidative agents were reduced partially due to increased glutathione (GSH) level. Mechanistically, GPRC5A regulates NF-κB mediated Vanin-1 expression which is the predominant enzyme for cysteamine generation. Administration of cystamine (the disulfide form of cysteamine) in GPRC5A deficient cell lines inhibited γ-GCS activity, leading to reduction of GSH level and increase of cell growth. Taken together, our studies suggest that GPRC5a is a potential biomarker for colon cancer and promotes tumorigenesis through stimulation of Vanin-1 expression and oxidative stress in colitis associated cancer. This study revealed an unexpected oncogenic role of GPRC5A in colorectal cancer suggesting there are complicated functional and molecular mechanism differences of this gene in distinct tissues. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
13. Potential Applications of DNA, RNA and Protein Biomarkers in Diagnosis, Therapy and Prognosis for Colorectal Cancer: A Study from Databases to AI-Assisted Verification.
- Author
-
Zhang, Xueli, Sun, Xiao-Feng, Shen, Bairong, and Zhang, Hong
- Subjects
- *
COLON tumors , *CELL proliferation , *APOPTOSIS , *ARTIFICIAL intelligence , *BIOMARKERS , *CELLULAR signal transduction , *DATABASES , *DNA , *MEDICAL information storage & retrieval systems , *METABOLISM , *PROTEINS , *RNA , *DISEASE progression , *PATHOLOGIC neovascularization , *EARLY detection of cancer , *DIAGNOSIS , *PROGNOSIS , *TUMOR treatment ,RECTUM tumors - Abstract
In order to find out the most valuable biomarkers and pathways for diagnosis, therapy and prognosis in colorectal cancer (CRC) we have collected the published CRC biomarkers and established a CRC biomarker database (CBD: http://sysbio.suda.edu.cn/CBD/index.html). In this study, we analysed the single and multiple DNA, RNA and protein biomarkers as well as their positions in cancer related pathways and protein-protein interaction (PPI) networks to describe their potential applications in diagnosis, therapy and prognosis. CRC biomarkers were collected from the CBD. The RNA and protein biomarkers were matched to their corresponding DNAs by the miRDB database and the PubMed Gene database, respectively. The PPI networks were used to investigate the relationships between protein biomarkers and further detect the multiple biomarkers. The Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway enrichment analysis and Gene Ontology (GO) annotation were used to analyse biological functions of the biomarkers. AI classification techniques were utilized to further verify the significances of the multiple biomarkers in diagnosis and prognosis for CRC. We showed that a large number of the DNA, RNA and protein biomarkers were associated with the diagnosis, therapy and prognosis in various degrees in the CRC biomarker networks. The CRC biomarkers were closely related to the CRC initiation and progression. Moreover, the biomarkers played critical roles in cellular proliferation, apoptosis and angiogenesis and they were involved in Ras, p53 and PI3K pathways. There were overlaps among the DNA, RNA and protein biomarkers. AI classification verifications showed that the combined multiple protein biomarkers played important roles to accurate early diagnosis and predict outcome for CRC. There were several single and multiple CRC protein biomarkers which were associated with diagnosis, therapy and prognosis in CRC. Further, AI-assisted analysis revealed that multiple biomarkers had potential applications for diagnosis and prognosis in CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
14. Epithelial Wntless is dispensable for intestinal tumorigenesis in mouse models.
- Author
-
Gao, Ganglong, Wei, Gaigai, Liu, Shijie, Chen, Jiwei, Zeng, Zhiyang, Zhang, Xinyan, Chen, Fangrui, Zhuo, Lingang, Hsu, Wei, Li, Dali, Liu, Mingyao, and Zhang, Xueli
- Subjects
- *
SMALL intestine , *INTESTINES , *NEOPLASTIC cell transformation , *INTESTINAL tumors , *WNT signal transduction , *MEMBRANE proteins , *MICE - Abstract
Wnt signaling is essential for the maintenance of adult stem cells and its aberrant activation is a stimulator of carcinogenesis. The transmembrane protein, Wntless, is an essential Wnt signaling component through regulating the secretion of Wnt ligands. Here, we generated a mouse model with specific Wntless knockout in intestinal epithelium to study its function in the intestinal epithelium. Wntless knockout exhibits no obvious defects in mice but significantly disrupted proliferation and differentiation of small intestinal organoids. We also discovered that these deficiencies could be partially rescued by Wnt3a supplement but not Wnt9b. To further investigate the role of Wntless in tumorigenesis, APC-deficient spontaneous intestinal tumors and chemical induced colorectal cancer mouse models were employed. To our surprise, intestinal epithelium-specific knockout of Wntless did not cause significant differences in tumor number and size. In summary, our data demonstrated that epithelial Wntless was required for the growth and differentiation of small intestinal organoids but not in live animals, suggesting the other tissues, such as mesenchymal tissue, play critical role for Wnt secretion in both intestinal homeostasis as well as tumorigenesis. • Deficiency of Wntless in intestinal epithelium is essential for the growth and differentiation of the small intestinal organoids. • This defect of small intestinal organoids could be partially rescued by Wnt3a supplement but not Wnt9b. • Intestinal epithelial Wnt secretion is not important for tumor development and growth in intestinal tumor mouse models. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.